Zymeworks BC Inc (ZYME) Unusual Options Activity Today

Checking ZYME unusual options activity helps you spot when traders are making outsized bets on Zymeworks BC Inc before the broader market catches on. Zymeworks BC Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor ZYME unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching ZYME unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking ZYME unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and ZYME unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas, breast, and colorectal cancer; and ZW49, a biparatopic anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate that is in Phase 1 clinical trial for the treatment of advanced or metastatic HER2-expressing tumors. The company has strategic partnerships with Merck Sharp & Dohme Research Ltd.; Eli Lilly and Company; Bristol-Myers Squibb company; GlaxoSmithKline Intellectual Property Development Ltd.; Daiichi Sankyo Co., Ltd.; Janssen Biotech, Inc.; BeiGene, Ltd.; and Exelixis, Inc.

It also has licensing and research collaboration with LEO Pharma A/S to research, develop, and commercialize bispecific antibodies; and Iconic Therapeutics, Inc. Zymeworks Inc. was incorporated in 2003 and is headquartered in Vancouver, Canada.

Catalysts rarely arrive without a footprint, and ZYME unusual options activity is often where that footprint shows up first. Our scanner tracks Zymeworks BC Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at ZYME unusual options volume on the call side or chasing put sweeps, Zymeworks BC Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.